Skip to main content
Jump to Page Content

Reading Hospital is the first hospital in the region to treat carotid artery disease and prevent future strokes using a new procedure called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven, minimally invasive and safe approach for high-risk surgical patients who need carotid artery treatment.

Carotid artery disease is a form of atherosclerosis, or a buildup of plaque, in the artery in the neck that carries blood to the brain. If left untreated, carotid artery disease can lead to stroke. About 400,000 new diagnoses of the disease are made every year in the United States alone.

TCAR is unique in that blood flow is temporarily reversed during the procedure so that any small bits of plaque that may break off during surgery are diverted away from the brain, preventing a stroke.  A stent is then placed inside the artery to stabilize the plaque, minimizing the risk of a future stroke.

Traditional treatment options, including open surgery with a large incision in the neck, may effectively treat the blockage but can pose more risks for certain patients. TCAR is performed in less than half the time of open surgery, which limits stress on the heart and reduces the risk of the patient having a stroke or heart attack during or after surgery. Since it is minimally invasive, patients who undergo the TCAR procedure recover more quickly and may go home the next day with less pain, smaller scars and fewer complications. TCAR patients can expect to return to full and productive lives and have a significantly reduced risk of stroke in the future.

 

Reading Hospital

Reading Hospital is the flagship, Magnet Recognized, acute care hospital of Tower Health. Located in West Reading, Pa., Reading Hospital is a 714-bed hospital that is home to many top-tier specialty care centers, including Reading HealthPlex, McGlinn Cancer Institute, Miller Regional Heart Center, Emergency Department, Level I Trauma Center and Beginnings Maternity Center, which houses the region's only Level III Neonatal Intensive Care Unit (NICU). With more than 1,000 physicians, specialists, and advanced practice providers across 49 locations, Reading Hospital has been recognized for its quality outcomes and clinical expertise across services lines. It is listed as one of America's 100 Best Hospitals for four consecutive years and received a 5-Star Rating from CMS two years in a row. For more information, visit towerhealth.org.

Related Articles

Tower Health Hospitals Earn National Healthgrades Recognition for Clinical Quality and Specialty Care in 2027

October 28, 2026 -Tower Health hospitals have again earned national recognition from Healthgrades for clinical quality in 2027, receiving 15 awards, rankings and ratings across multiple medical and surgical specialties.

Scalp Cooling Technology Helps Cancer Patients Manage Hair Loss During Chemotherapy

October 28, 2026 - People with cancer undergoing chemotherapy at Reading Hospital’s McGlinn Cancer Institute now have access to scalp cooling technology that can help reduce hair loss, without the added expense or travel previously required to access the treatment. 

Dedicated Runner Hopes to Reach Milestone with 50th Half Marathon at Reading Hospital Road Run in October

October 13, 2026 - The goal for runner Adam Hughes: 655 miles, 50 races, and one more free banana at the finish line.